AI in Biotech Research: Boon or Bane?
Philip Crowley
November 29, 2024
Is artificial intelligence a boon or a bane—or perhaps a bit of both? Just a few years ago, discussions about
Is artificial intelligence a boon or a bane—or perhaps a bit of both? Just a few years ago, discussions about
How AI Is Shaping Life Sciences: Challenges, Risks and Future Prospects Artificial intelligence (“AI”) has become a buzzword—almost every article,
In the first quarter of 2024, weekly cyberattacks against U.S. companies rose to an all-time high of 1,308—a 28% increase
We recently attended an insightful seminar on biotech manufacturing that we’d like to share with you. On September 13, 2024,
Artificial intelligence has become a buzzword—every article, news bulletin, podcast, and other digital media seems to mention it. Looking back
Great news for prevention of respiratory syncytial virus (“RSV”) infections! Here’s a quick summary of the article: RSV is a common
The BioNJ 31st Annual Dinner Meeting and Innovation Celebration, held on February 8, 2024, was a significant event that showcased
Bio NJ has some tremendous opportunities for C-suite executives at life sciences companies. Bio NJ has established a networking and
Here’s a great opportunity for those interested in biomedical research and entrepreneurship. The Biomedical Engineering Department at Stevens Institute of Technology
Orphan drug development is a crucial and complex area of pharmaceutical research. It’s dedicated to creating treatments for rare diseases.
Losing one’s sight is one of the cruelest types of disabilities. We depend on that sense for so much of
The realm of medical devices has seen remarkable advancements in 2023. Innovators need to be aware of these advancements to
Key Highlights: · Strategic Shift: CRISPR Therapeutics is pivoting from cancer drug development to cell-based medicines for autoimmune
It’s not just your hometown physician’s travel bag anymore! In the dynamic field of life sciences, cell and gene therapy
One of the features that excites me about representing life sciences and other technology innovators is the impact they can
We live in an extraordinary time. It’s a time where technology in life sciences is peeling back the curtain on
Stevens Institute of Technology (“Stevens”) has announced some great results impacting cancer therapies. In this note, I’ll describe Crowley Law is
A new investigational therapy from Celldex Therapeutics Inc. in Hampton, New Jersey provides the promise of substantial relief from “hives”,
Diabetes can be a silent, slow killer. Over time, its detrimental effects on the body can result in life-altering complications.
Come hear a distinguished leader of the pharmaceutical industry speak about the impact of technology on the biopharmaceutical industry. Dr.
Do you think of Arnold Schwarzenegger in the film “Terminator” whenever we talk about “artificial intelligence”?! It really doesn’t have
Pharmaceutical regulators are open to new kinds of data to support new drug applications. However, that doesn’t mean that applicants can ignore
There’s no stopping Mother Nature when she gets going. The striking force of a tornado recently tore through a Pfizer
Crowley Law LLC is proud to support Hope Through Education and their mission is to help thousands of underprivileged students reach their full potential through the gift of a great education. Learn more about this organization.
